Literature DB >> 8742644

Basal and stimulated gastrin levels and gastric acid output five months after therapy for Helicobacter pylori eradication in duodenal ulcer patients.

J P Gisbert1, D Boixeda, T Vila, L de Rafael, C Redondo, C M de Argila.   

Abstract

The aim of our study was to demonstrate the effect of Helicobacter pylori eradication on basal and stimulated serum gastrin levels and gastric acid output 5 months after therapy of patients with duodenal ulcer. Thirty-two patients (24 men and eight women with a mean age of 45 years) who had had endoscopy and were diagnosed as having duodenal ulcer entered the study. In all patients three biopsy specimens were taken from the duodenal bulb, gastric antrum, body, and fundus. These specimens were then sent for microbiological and histological examination. Triple therapy consisting of bismuth, metronidazole, and tetracycline was administered. Endoscopy was repeated 1 and 5 months after therapy, and biopsy specimens were again taken from the gastric antrum and body. Before treatment, serum samples were taken to measure basal and stimulated (90 min) gastrin levels after ingestion of two beef cubes, and basal and stimulated acid outputs (after pentagastrin) were studied. Measurements of gastrin and gastric acid output were repeated 5 months after therapy. H. pylori was eradicated in 26 patients (81.3%). Basal gastrin levels (mean +/- SD) at diagnosis and after eradication were 44 +/- 12 and 35.8 +/- 2 pg/ml, respectively (p < 0.05). Similarly, stimulated gastrin levels (integrated values) decreased from 5,303 +/- 1,526 pg/ml/min before therapy to 3,779 +/- 1,204 pg/ml/min after eradication (p < 0.001). However, basal (4.9 +/- 4mEq/h) and stimulated (28.5 +/- 10mEq/h) acid output did not vary after eradication (3.9 +/- 4 mEq/h and 26.2 +/- 12 mEq/h, respectively). We conclude that basal and stimulated gastric acid output are not changed by H. pylori eradication in duodenal ulcer patients 5 months after therapy, in spite of its association with a significant decrease in basal and stimulated gastrin levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8742644     DOI: 10.1097/00004836-199603000-00003

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

1.  Helicobacter pylori infection and gastrointestinal hormones:a review.

Authors:  Xiang-Qian Huang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Helicobacter pylori, gastric acid, and duodenal gastric metaplasia.

Authors:  K E McColl
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

3.  Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection.

Authors:  T Rokkas; S D Ladas; C Liatsos; E Panagou; A Karameris; S A Raptis
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

4.  Gastrin and antral G cells in course of Helicobacter pylori eradication: six months follow up study.

Authors:  Aleksandra Sokic-Milutinovic; Vera Todorovic; Tomica Milosavljevic; Marjan Micev; Neda Drndarevic; Olivera Mitrovic
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

5.  Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; G Bisso; M Pivari; C Mansi; L Tessieri; G Lapertosa; P Ceppa; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

6.  Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication.

Authors:  K Iijima; S Ohara; H Sekine; T Koike; K Kato; S Asaki; T Shimosegawa; T Toyota
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.